[1]
B. Ramezanpour, T. Riemens, L. van de Burgwal, and E. Claassen, “An interdisciplinary analysis of genetically modified vaccines: from clinical trials to market”, Int J Clin Trials, vol. 2, no. 4, pp. 64–74, Nov. 2015.